Gene therapy shows promise in tackling X-linked RP
Early results from clinical testing of a gene therapy to treat X-linked retinitis pigmentosa (XLRP) have shown partial reversal of sight loss in some patients.
Search results
Early results from clinical testing of a gene therapy to treat X-linked retinitis pigmentosa (XLRP) have shown partial reversal of sight loss in some patients.
Dr Graham undertook research into the basic mechanisms of retinal vasculitis, inflammation of the blood vessels in the retina, and is an important cause of poor vision in patients with uveitis, inflammation of the uveal tract.
Join us for our upcoming webinar!
Are you affected by inherited sight loss? We are here to help.
If you, or a close relative, are living with a genetic sight loss condition, there may be a chance that your children will inherit it.
Dr Nikolas Pontikos is a Senior Research Fellow at UCL Institute of Ophthalmology, and has been working on inherited retinal conditions for several years.
Cycle with #TeamRetinaUK at Ride Reigate 2026 and get behind our ground-breaking work.
Join #TeamRetinaUK for an unforgettable Kiltwalk adventure in Glasgow, Aberdeen, Dundee or Edinburgh, throughout 2026.
Join #TeamRetinaUK for an unforgettable Kiltwalk adventure in Glasgow, Aberdeen, Dundee or Edinburgh, throughout 2026.
James was part of #TeamRetinaUK in 2020 when he took part in the first ever Virtual London Marathon. He talks about his experience and his motivation.